-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
-
Summary
-
Can-Fite BioPharma Ltd. quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q4 2016 to Q2 2025.
- Can-Fite BioPharma Ltd. Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Jun 2025 was $6.45M, a 36.8% increase year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)